Supreme Court court seeks review of drug pricing policy

Last Updated: Thursday, July 16, 2015, 19:22

The Supreme Court has asked the central government to reexamine its pricing policy for essential medicines after a group of non-governmental organisations challenged the provisions, a lawyer involved in the case said.

Dr Reddy's launches hair growth supplement

Last Updated: Friday, June 19, 2015, 21:08

The supplement provides key nutrients needed for maintaining healthy hair and according to the company, has a unique formula including grape seed extract containing potent antioxidants.

Novartis India arm says unaware of any delisting plan

Last Updated: Thursday, June 11, 2015, 19:51

"The board of the company has not received any notice from the promoters of the company, Novartis AG, on its intention to delist the equity shares of the company from the Bombay Stock Exchange Limited," Novartis India said in a statement after trading hours.

Teva poised to raise its stake in Mylan: Sources

Last Updated: Wednesday, June 3, 2015, 10:12

The strategy is a sign of Teva`s commitment to its $40 billion bid for Mylan, as the latter presses on with its own $34 billion hostile bid for over-the-counter drug company Perrigo Company Plc .

Cadila Healthcare near deal to buy smaller rival Claris: Report

Last Updated: Thursday, May 21, 2015, 10:45

Cadila Healthcare Ltd, among India`s top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), a financial daily reported on Thursday, citing sources aware of the talks.

Drug makers' tax benefit claim on freebies, gifts unlawful: CAG

Last Updated: Sunday, May 10, 2015, 14:36

Slamming the practice of pharma companies offering freebies and gifts to doctors, government auditor CAG said that drug makers have claimed tax benefits on such expenses despite these being prohibited by law.

Indian companies not singled out for inspections, says USFDA

Last Updated: Wednesday, March 18, 2015, 20:29

The US health regulator said it is looking to increase training and joint inspections in various areas, including manufacturing while also discussing possibility of information sharing with Indian officials.

Several Indian cos get FDA nod for anti-depressant drug

Last Updated: Thursday, December 12, 2013, 10:25

In a major boost to some of the Indian drug makers, the US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used in treatment of depression and other conditions.

US FDA for greater freedom to generic cos in product labelling

Last Updated: Sunday, November 17, 2013, 18:46

Generic manufacturers, which make cheaper but therapeutically equivalent versions of innovative drugs, would be required to inform the brand name manufacturer about the labelling change.

Indian firms get FDA approval for 110 generic drugs

Last Updated: Sunday, September 15, 2013, 12:56

Drugmakers from India, the biggest overseas source of medicines sold in the US, have got more than 100 generic drug approvals from the American health regulator FDA this year so far.

Indian pharma draws more scrutiny as US exports rise

Last Updated: Sunday, September 15, 2013, 08:59

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories, face closer FDA scrutiny as the agency ramps up its presence in the country.

US to hike fees for generic drugmakers; Indian firms to be hit

Last Updated: Sunday, August 11, 2013, 12:27

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October.